logo
Ask the Advocate: How to Get Workplace Accommodations with Tardive Dyskinesia

Ask the Advocate: How to Get Workplace Accommodations with Tardive Dyskinesia

Health Line16-05-2025

A patient advocate with tardive dyskinesia talks about his experiences working with the condition and requesting accommodations at his job to manage it.
Tardive dyskinesia (TD) may cause involuntary movements in various parts of your body, such as your tongue, face, neck, torso, or limbs. These movements might make it challenging for you to do certain activities, including some tasks at work.
In a 2023 survey of people with TD in the United States, roughly 74% said the condition had negatively affected their work. Nearly one-third of survey participants said that TD had caused them to miss work, and more than two-thirds said it had reduced their productivity at work.
Many of the survey participants also reported experiencing negative reactions to their symptoms from other people, including employers or co-workers. These reactions can add to the challenges of managing the condition at work.
Some people with TD might benefit from workplace accommodations — changes to a work environment or job that help people with disabilities perform their essential job functions and enjoy equal employment benefits and privileges. Educating employers or co-workers about TD might also help some people manage work-related challenges related to the condition.
Deciding whether you want to ask for workplace accommodations or tell your employer or co-workers about your condition is a personal choice.
We spoke with Dan B., a 64-year-old resident of Los Angeles who works in sales, to learn about his experiences working with TD and requesting workplace accommodations.
This interview has been edited for brevity, length, and clarity.
How does TD affect you at work?
I've been at my current job for 6 years, and it's been really hard with the TD for the past year and a half. The TD has been coming on for several years, but it's gotten worse in the past year and a half to 2 years.
I work in phone sales for a living. I'm very good at my job, and the clients can't see my symptoms on the phone, which makes it easier to deal with. It's easier to get sales on the phone than it would be face-to-face.
But people in my office have difficulty looking me in the eye. It's very obvious, and it has isolated me from building relationships with anybody in the office, other than a couple of people I work very close to.
Before my jaw symptoms got really bad, I had developed office friendships with a few people on the other side of the office. They still acknowledge me and talk with me a little bit, but they don't want to look me in the eye.
I used to be very gregarious and outgoing, and now I'm really isolated. I don't carry on conversations anymore because my co-workers can't handle it. They're too embarrassed or too uncomfortable to look at me.
Have you asked for accommodations to manage the condition?
Yes — my boss lets me work from home when my jaw is really bad.
It keeps me from being stressed about having to be seen by my co-workers.
There's nothing formal in writing. We just approach it on a day-to-day basis. I text him in the morning, saying, 'My jaw is really bad today. Can I work from home?' And he has always said yes. It's usually a couple of times a week that I don't go into the office and I work from home.
We're also moving offices on June 1, and things will be a little different there. It will just be 5 or 6 of us in the new office, rather than 30. Everybody will know about my symptoms, and I might even get my own area to work in, so that will be a good move.
I haven't approached many of my co-workers to explain the condition, but I did approach the ones that I work close to. I told them that the symptoms were part of a health condition I have.
Do you have tips for others who are managing TD at work?
It depends on the relationship that you have with your boss — but if you can, I would be honest. Let them know what you've got and what causes it.
I explained the condition to my boss. I'm not sure he understood it all, but I basically told him that it's a side effect of medication that I use for my Tourette syndrome, and it's something that I can't control.
I have a close relationship with him, which helps. Our team is small and tight-knit. His door is always open. Even if he's busy, he'll let us come in and ask questions or talk.
If you're in an environment where your boss sits in an office that's not easily accessible or they're managing a lot of people, I'm sure the dynamics would be different.
Learn more about workplace accommodations
A workplace accommodation is an adjustment to a job, work environment, or hiring process that helps someone with a disability successfully perform their job tasks and enjoy equal employment opportunities.
You have a legal right to reasonable accommodations under Title I of the Americans with Disabilities Act (ADA) if you:
are qualified for the job
meet the legal definition of having a disability
need a job accommodation due to your disability
work for an organization that has at least 15 employees
Most organizations with fewer than 15 employees aren't legally required to provide reasonable accommodations, but they may voluntarily choose to do so.
You can visit the Job Accommodation Network to learn more about your rights and to find tips on requesting accommodations.
Dan B. is a 64-year-old resident of Los Angeles, California, who works in sales. He developed tardive dyskinesia symptoms in his jaw and other parts of his body as a side effect of treatment with haloperidol (Haldol), a medication that his doctor prescribed for Tourette syndrome. He loves animals, has lived in multiple states across the country, and values the friendships that he has developed with people across those states.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Denver Fork Cancer event to fight cancer, raise awareness for patients one bite at a time
Denver Fork Cancer event to fight cancer, raise awareness for patients one bite at a time

CBS News

time2 hours ago

  • CBS News

Denver Fork Cancer event to fight cancer, raise awareness for patients one bite at a time

Fundraiser called Fork Cancer to take place in July in Denver Fundraiser called Fork Cancer to take place in July in Denver Fundraiser called Fork Cancer to take place in July in Denver In Colorado, about one-in-two men and two-in-five women will be diagnosed with some form of cancer in their lifetimes. It's a common disease in our state, with about 25,000 Coloradans diagnosed every year. American Cancer Society Cancer Action Network But Fork Cancer, hosted by the American Cancer Society Cancer Action Network, is helping fight cancer. American Cancer Society Cancer Action Network The party with a purpose features Denver fine culinary establishments while offering a variety of small plates, spirits and brews, and live entertainment acts. Ocular melanoma survivor Katie Doble will also share her powerful story of resilience. American Cancer Society Cancer Action Network You're invited to Fork Cancer, July 17th at 6:30pm at Mile High Station. CBS Colorado Anchor Mekialaya White will host the event. Tickets are available here.

Part D Cancer Drug Launch Prices Soar Past Inflation
Part D Cancer Drug Launch Prices Soar Past Inflation

Medscape

time3 hours ago

  • Medscape

Part D Cancer Drug Launch Prices Soar Past Inflation

Launch prices for Medicare Part D anticancer drugs have risen sharply since 2012, with a mean increase of $1694 per year. In 2025, the observed prices were 15%-200% higher than expected if the increases were due to inflation alone, but the gap between observed and inflation-adjusted prices narrowed over the study period. METHODOLOGY: The Inflation Reduction Act of 2022 introduced price negotiation for Medicare-covered drugs and required manufacturers to pay rebates to Medicare for price increases above inflation. But it did not address the launch prices of new drugs. Anticancer drugs, a protected drug class with mandatory Medicare Part D coverage, may now be especially prone to higher launch prices, in part because the Inflation Reduction Act limits out-of-pocket spending and price increases after market entry. Researchers identified 86 branded, self-administered, molecularly targeted anticancer therapies approved by the FDA between January 2010 and December 2024. Data on drug prices were obtained from the Medicare Prescription Drug Plan Formulary and adjusted for inflation. The researchers looked at launch prices by year and compared drug prices in 2025 with those expected if launch prices had increased due to inflation alone since the drug's market entry. TAKEAWAY: The mean monthly launch price increased from $10,954 for drugs first observed in the Medicare formulary in 2012-2014 to $27,891 for drugs first observed in 2023-2025. After adjusting for inflation, the mean launch price increased by $1694 per year ( P < .001). < .001). In 2025, actual drug prices were 14.8%-200.9% higher than expected if they had only kept pace with inflation. Although the gap between observed and inflation-adjusted prices narrowed over time, price increases continued to outpace inflation in 2023 and 2024, despite the Inflation Reduction Act rebate requirement, which will result in rebates to Medicare starting in fall 2025. IN PRACTICE: 'Launch prices for self-administered targeted anticancer therapies have grown precipitously, although no evidence was found of disproportionate increases in recent years. Instead, continued launch price growth for anticancer therapies was observed, consistent with prior research,' the study authors wrote. 'This suggests that companies were already engaging in price maximization for anticancer therapies and continued to do so after the implementation of the [Inflation Reduction Act].' SOURCE: This study, led by Stacie B. Dusetzina, PhD, Vanderbilt University School of Medicine in Nashville, Tennessee, was published online in JAMA . LIMITATIONS: This study used example indications to determine monthly doses and pricing. Additionally, variations in available price measures were noted over the study period. DISCLOSURES: This study was funded by Arnold Ventures. Several authors reported receiving grants or personal fees and having other ties with various sources.

New York lawmakers approve bill that would allow medically assisted suicide for the terminally ill
New York lawmakers approve bill that would allow medically assisted suicide for the terminally ill

Washington Post

time4 hours ago

  • Washington Post

New York lawmakers approve bill that would allow medically assisted suicide for the terminally ill

ALBANY, N.Y. — Terminally ill New Yorkers would have the legal ability to end their own lives with pharmaceutical drugs under a bill passed Monday in the state Legislature. The proposal, which now moves to the governor's office, would allow a person with an incurable illness to be prescribed life-ending drugs if he or she requests the medication and gets approval from two physicians. A spokesperson for New York Gov. Kathy Hochul said she would review the legislation.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store